4/24
08:31 pm
bmrn
BioMarin (BMRN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
Neutral
Report
BioMarin (BMRN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
4/24
06:23 pm
bmrn
BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings Estimates [Yahoo! Finance]
Low
Report
BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings Estimates [Yahoo! Finance]
4/24
05:25 pm
bmrn
BioMarin updated 2024 guidance sees EPS raise, but no change to revenue [Seeking Alpha]
Low
Report
BioMarin updated 2024 guidance sees EPS raise, but no change to revenue [Seeking Alpha]
4/24
04:14 pm
bmrn
BioMarin Reports Record Financial Results for the First Quarter 2024 [Yahoo! Finance]
Low
Report
BioMarin Reports Record Financial Results for the First Quarter 2024 [Yahoo! Finance]
4/24
04:13 pm
bmrn
BioMarin Pharmaceutical Non-GAAP EPS of $0.71 beats by $0.11, revenue of $648.83M misses by $2.98M [Seeking Alpha]
Low
Report
BioMarin Pharmaceutical Non-GAAP EPS of $0.71 beats by $0.11, revenue of $648.83M misses by $2.98M [Seeking Alpha]
4/24
04:03 pm
bmrn
BioMarin Reports Record Financial Results for the First Quarter 2024
Medium
Report
BioMarin Reports Record Financial Results for the First Quarter 2024
4/23
01:10 pm
bmrn
Is a Surprise Coming for BioMarin (BMRN) This Earnings Season? [Yahoo! Finance]
Low
Report
Is a Surprise Coming for BioMarin (BMRN) This Earnings Season? [Yahoo! Finance]
4/22
10:56 am
bmrn
Gear Up for BioMarin (BMRN) Q1 Earnings: Wall Street Estimates for Key Metrics [Yahoo! Finance]
Low
Report
Gear Up for BioMarin (BMRN) Q1 Earnings: Wall Street Estimates for Key Metrics [Yahoo! Finance]
4/19
07:39 am
bmrn
AAV Vectors in Gene Therapy Pipeline Landscape Report 2024: Comprehensive Insights about 70+ Companies and 235+ Pipeline Drugs [Yahoo! Finance]
Low
Report
AAV Vectors in Gene Therapy Pipeline Landscape Report 2024: Comprehensive Insights about 70+ Companies and 235+ Pipeline Drugs [Yahoo! Finance]
4/17
05:35 am
bmrn
World Hemophilia Day 2024"Equitable access for all: recognizing all bleeding disorders"
Low
Report
World Hemophilia Day 2024"Equitable access for all: recognizing all bleeding disorders"
4/17
12:07 am
bmrn
World Hemophilia Day 2024"Equitable access for all: recognizing all bleeding disorders" [Yahoo! Finance]
Low
Report
World Hemophilia Day 2024"Equitable access for all: recognizing all bleeding disorders" [Yahoo! Finance]
4/11
07:34 pm
bmrn
First clinical trial of vosoritide for children with hypochondroplasia shows increased growth [Yahoo! Finance]
Low
Report
First clinical trial of vosoritide for children with hypochondroplasia shows increased growth [Yahoo! Finance]
4/10
08:00 am
bmrn
BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ET
Low
Report
BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ET
3/25
04:01 am
bmrn
Jean-Jacques Bienaimé Appointed Chairman of the Board at Owkin [Yahoo! Finance]
Low
Report
Jean-Jacques Bienaimé Appointed Chairman of the Board at Owkin [Yahoo! Finance]
3/12
08:52 am
bmrn
New Data to be Presented for BioMarin's VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting [Yahoo! Finance]
Low
Report
New Data to be Presented for BioMarin's VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting [Yahoo! Finance]
3/12
08:30 am
bmrn
New Data to be Presented for BioMarin's VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
Low
Report
New Data to be Presented for BioMarin's VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
3/8
01:42 am
bmrn
Insider Sell: President, Worldwide R&D Henry Fuchs Sells 35,341 Shares of Biomarin ... [Yahoo! Finance]
Low
Report
Insider Sell: President, Worldwide R&D Henry Fuchs Sells 35,341 Shares of Biomarin ... [Yahoo! Finance]
3/7
08:41 am
bmrn
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer [Yahoo! Finance]
Low
Report
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer [Yahoo! Finance]
3/7
08:30 am
bmrn
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
Low
Report
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
3/1
09:18 am
bmrn
BioMarin Scheduled to Participate in March Investor Conferences [Yahoo! Finance]
Low
Report
BioMarin Scheduled to Participate in March Investor Conferences [Yahoo! Finance]
3/1
09:00 am
bmrn
BioMarin Scheduled to Participate in March Investor Conferences
Low
Report
BioMarin Scheduled to Participate in March Investor Conferences
2/29
10:55 am
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "hold" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $91.00 price target on the stock.
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "hold" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $91.00 price target on the stock.
2/27
12:21 am
bmrn
Decoding Biomarin Pharmaceutical Inc (BMRN): A Strategic SWOT Insight [Yahoo! Finance]
Low
Report
Decoding Biomarin Pharmaceutical Inc (BMRN): A Strategic SWOT Insight [Yahoo! Finance]
2/26
03:30 pm
bmrn
BioMarin Pharma gets DOJ subpoena on sponsored testing programs for two therapies [Reuters]
Low
Report
BioMarin Pharma gets DOJ subpoena on sponsored testing programs for two therapies [Reuters]
2/26
02:40 pm
bmrn
UPDATE 1-BioMarin Pharma gets DOJ subpoena on sponsored testing programs for two therapies [Yahoo! Finance]
Low
Report
UPDATE 1-BioMarin Pharma gets DOJ subpoena on sponsored testing programs for two therapies [Yahoo! Finance]